Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
Peritogiannis
Vaios
V
Goulia
Panagiota
P
Pappas
Dimitrios
D
Hyphantis
Thomas
T
Mavreas
Venetsanos
V
D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced*; D000077582:Amisulpride; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003863:Depression / Q000150:complications / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000175:diagnosis; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D020280:Sertraline / Q000009:adverse effects* / Q000627:therapeutic use; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000077582:Amisulpride; D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D013469:Sulpiride